本页面由Tiger Trade Technology Pte. Ltd.提供服务

Atara Biotherapeutics

4.71
-0.1600-3.29%
盘后4.780.0700+1.49%19:57 EDT
成交量:3.22万
成交额:15.23万
市值:3,851.89万
市盈率:1.83
高:4.97
开:4.86
低:4.60
收:4.87
52周最高:19.15
52周最低:3.92
股本:817.81万
流通股本:560.06万
量比:0.50
换手率:0.58%
股息:- -
股息率:- -
每股收益(TTM):2.57
每股收益(LYR):-11.4053
净资产收益率:-2014.86%
总资产收益率:47.81%
市净率:-1.00
市盈率(LYR):-0.41

数据加载中...

2025/01/16

重要事件披露

Form 8-K - Current report
2024/12/23

重要事件披露

Form 8-K - Current report
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/05

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]